Patients requiring oral corticosteroids should be weaned slowly from systemic corticosteroid use after transferring to Advair Diskus. Prednisone reduction can be accomplished by reducing the daily prednisone dose by mg on a weekly basis during therapy with Advair Diskus. Lung function (mean forced expiratory volume in 1 second [FEV 1 ] or morning peak expiratory flow [AM PEF]), beta-agonist use, and asthma symptoms should be carefully monitored during withdrawal of oral corticosteroids. In addition, patients should be observed for signs and symptoms of adrenal insufficiency, such as fatigue, lassitude, weakness, nausea and vomiting, and hypotension.
Register for alerts
If you have registered for alerts, you should use your registered email address as your username
Committee Opinion Committee on Obstetric Practice Number 210, October 1998 Antenatal Corticosteroid Therapy for Fetal Maturation
2. NIH Consensus Statement Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes1994 Feb 28-Mar 2;12(2):1-24
3. Morrison JC, Whybrew WD, Bucovaz ET, Schneider JM. Injection of corticosteroids into mother to prevent neonatal respiratory distress syndrome. Am J Obstet Gynecol 131:358,1978. MEDLINE
4. Morrison JC, Schneider JM, Whybrew WD, Bucovaz ET. Effect of corticosteroids and Fetomaternal disorders on the L:S ratio. Obstet Gynecol 56:583, 1980 MEDLINE Please review the Disclaimer before using this site. Copyright © 2000-2008 by Focus Information Technology.
All rights reserved.